| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 01/22/1997 | EP0754753A1 Novel human tissue-type plasminogen activator variant |
| 01/22/1997 | EP0754688A2 Dioxolane intermediates |
| 01/22/1997 | EP0754687A1 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 01/22/1997 | EP0754463A2 Stabilized aqueous liquid preparation of blood coagulation factor XIII |
| 01/22/1997 | EP0754461A2 A preservation solution of blood platelets |
| 01/22/1997 | EP0754187A1 Growth arrest homeobox gene |
| 01/22/1997 | EP0754058A1 Wound healing |
| 01/22/1997 | EP0754053A1 Novel hemostatic composition |
| 01/22/1997 | CN1141061A Thrombopoietin |
| 01/21/1997 | US5596009 Fused benzeneoxyacetic acid derivatives |
| 01/21/1997 | US5595999 Guanidine derivatives |
| 01/21/1997 | US5595974 Batroxobin with heparin for cardiovascular disorders |
| 01/21/1997 | US5595973 Protection of hemopoietic cells during chemotherapy or radiotherapy |
| 01/21/1997 | US5595903 Expression vectors, host cells |
| 01/21/1997 | CA2100918C Oxime derivative |
| 01/21/1997 | CA2028235C Condensed purine derivatives |
| 01/16/1997 | WO1997001569A1 Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a |
| 01/16/1997 | WO1997001360A2 Compounds with chelation affinity and selectivity for first transition series elements and their use in medical therapy and diagnosis |
| 01/16/1997 | WO1997001338A1 Pyridinone-thrombin inhibitors |
| 01/16/1997 | CA2224437A1 Pyridinone-thrombin inhibitors |
| 01/16/1997 | CA2224346A1 Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a |
| 01/15/1997 | EP0753304A1 Thrombolytic enzyme and method of obtaining same |
| 01/15/1997 | EP0753299A1 A formulation for iron chelation and a process for preparing same |
| 01/15/1997 | EP0752878A1 Products comprising substrates capable of enzymatic cross-linking |
| 01/15/1997 | EP0752874A1 Enhanced virus-mediated dna transfer |
| 01/15/1997 | EP0752867A1 Selective cell proliferation |
| 01/15/1997 | EP0752863A1 Use of biopolymers for digestive tract injuries treatment |
| 01/15/1997 | CN1140456A Superagonists and antagonists of H IL-6, and 3-D modelling method for their selection |
| 01/15/1997 | CN1140454A Novel mercaptoacetylamido-1,3,4,5-tetrahydro-benzo|c¨ azepin-3-one disulfide derivs. useful as inhibitors of enkephalinase and ACE |
| 01/15/1997 | CN1140413A Humanized antibodies against leukocyte adhesion molecule VLA-4 |
| 01/15/1997 | CN1140410A Vitamin E and derivs. preventing damage in red cells sterilized by phthalocyanines and light |
| 01/14/1997 | US5594023 1,3-dihydroindol-2-one derivatives substituted in the 3-position by a nitrogen-containing group, their preparation and the pharmaceutical compositions in which they are present |
| 01/14/1997 | US5593992 Cytokine inhibitors |
| 01/14/1997 | US5593990 Methods and compositions for inhibition of angiogenesis |
| 01/14/1997 | US5593968 Virus-inactivated factor Xa preparation |
| 01/14/1997 | US5593622 Preparation of liposomes with peg-bound phospholipid on surface |
| 01/14/1997 | CA2046929C T-pa pro stabilisation |
| 01/14/1997 | CA2046598C T-pa solubilisation |
| 01/09/1997 | DE19524765A1 Neue Oxazolidinonderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel New oxazolidinone derivatives, processes for their preparation and medicaments containing these compounds |
| 01/08/1997 | EP0752005A1 Compacted nucleic acids and their delivery to cells |
| 01/08/1997 | EP0751936A1 New 1,4-disubstituted piperidine derivatives useful as medicaments acting on the glutamate receptor |
| 01/08/1997 | EP0751932A1 Vitamin-d amide derivatives |
| 01/08/1997 | EP0751785A1 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof |
| 01/08/1997 | EP0751773A1 Tocolytic oxytocin receptor antagonists |
| 01/08/1997 | EP0751709A1 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 01/08/1997 | EP0473724B1 A human cytokine, interleukin-9 |
| 01/08/1997 | CN1139955A Human kunitz-type protease inhibitors |
| 01/08/1997 | CN1139932A N-terminally chemically modified protein compositions and methods |
| 01/08/1997 | CN1139928A Novel compound |
| 01/08/1997 | CN1033760C Protein with 8th activity factor, process for its preparation using genetic engineering cell and pharmaceutical composition containing it |
| 01/07/1997 | US5591772 Dietary supplements |
| 01/07/1997 | US5591769 Cyclic imino derivatives and pharmaceutical compositions containing them |
| 01/07/1997 | US5591710 Compositions and methods utilizing nitroxides to avoid oxygen toxicity, particularly in stabilized, polymerized, conjugated, or encapsulated hemoglobin used as a red cell substitute |
| 01/07/1997 | US5591640 Functional DNA block and plasmid coding for hirudin, transformed yeast, method for preparing hirudin, hirudin obtained and its pharmaceutical use |
| 01/07/1997 | US5591633 Nucleic acids encoding human placental coagulation inhibitor (PCI) |
| 01/07/1997 | CA2024381C Xanthine compounds |
| 01/07/1997 | CA2011329C Xanthine derivatives |
| 01/02/1997 | EP0751219A1 Platelet aggregation inhibitors |
| 01/02/1997 | EP0750631A1 Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo(c)azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 01/02/1997 | EP0750628A1 Fibroblast growth factor-10 |
| 01/02/1997 | EP0564461B1 The use of antibodies to tnf or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor |
| 01/02/1997 | EP0477295B1 Platelet aggregation inhibitors |
| 01/01/1997 | CN1139455A Thrombin mutants |
| 01/01/1997 | CN1139435A New ginkgolide derivatives and process for preparing them |
| 12/31/1996 | US5589572 Process for production of inhibited forms of activated blood factors |
| 12/31/1996 | US5589571 Process for production of inhibited forms of activated blood factors |
| 12/31/1996 | US5589496 Fused benzeneoxyacetic acid derivatives which have PGI2 receptor agonist activity |
| 12/31/1996 | US5589359 Chimeric proteins |
| 12/31/1996 | US5589154 Diagnosing presence of b-amyloid peptide |
| 12/31/1996 | CA2019745C Preparation for treating and preventing thromboses and thromboembolic complications, use of such a preparation and a method of producing the same |
| 12/27/1996 | WO1996041868A2 Prothrombin derivatives |
| 12/27/1996 | WO1996041818A1 Chitin hydrogels, methods of their production and use |
| 12/27/1996 | WO1996041816A1 Factor ix binding peptides, derived from factor viii and their use as inhibitors of blood coagulation |
| 12/27/1996 | WO1996041814A1 Peptide, bronchodilator and blood flow ameliorant |
| 12/27/1996 | WO1996041645A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations |
| 12/27/1996 | WO1996041640A1 Bradykinin analogs as selective thrombin inhibitors |
| 12/27/1996 | WO1996041626A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 12/27/1996 | WO1996041625A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor |
| 12/27/1996 | EP0750044A2 DNA constructs and transfection of cells therewith for homologous recombination |
| 12/27/1996 | EP0749979A2 Method and composition for treating thrombosis |
| 12/27/1996 | EP0749444A1 Hybrid human/animal factor viii |
| 12/27/1996 | EP0749428A1 Isoxazoline compounds as inhibitors of tnf release |
| 12/27/1996 | EP0749424A1 Naphthalene derivatives as prostaglandin i2 agonists |
| 12/27/1996 | EP0749320A1 Fibrin-specific antibody for use as an antithrombotic agent |
| 12/27/1996 | EP0749318A1 Method of stimulating hematopoiesis with hemoglobin |
| 12/27/1996 | EP0749316A1 Antithrombotic agents |
| 12/27/1996 | CA2224634A1 Prothrombin derivatives |
| 12/27/1996 | CA2224563A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations |
| 12/27/1996 | CA2224517A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 12/27/1996 | CA2224379A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor |
| 12/27/1996 | CA2224253A1 Chitin hydrogels, methods of their production and use |
| 12/27/1996 | CA2221567A1 Factor ix binding peptides, derived from factor viii and their use as inhibitors of blood coagulation |
| 12/25/1996 | CN1138583A 9-substituted 2-(2-n-alkoxyphenyl)-purin-6-ones |
| 12/25/1996 | CN1138474A Antissepsis, antiinflammation and hemostasis capsules |
| 12/24/1996 | US5587368 Administration of a 27-hydroxycholesterol or related compound or sterol-27-hydroxylase stimulant to prevent restenosis following vascular endothelial injury |
| 12/24/1996 | US5587360 Platelet adhesion inhibitor |
| 12/19/1996 | WO1996040920A1 Modified hemoglobin-like compounds and methods of purifying same |
| 12/19/1996 | WO1996040784A2 Method of solubilizing, purifying, and refolding protein |
| 12/19/1996 | WO1996040782A1 Separation of hemoglobin on hydroxyapatite using hplc |
| 12/19/1996 | WO1996040779A1 Peptide fragments of tissue factor and their use for treatment and prevention of clotting disorders |